Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs

Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism

(2008) Thien T. Tran et al.   Cell Metabolism

Visceral Adiposity, Not Abdominal Subcutaneous Fat Area, Is Associated With an Increase in Future Insulin Resistance in Japanese Americans

(2008) T. Hayashi et al.   DIABETES

Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice

(2008) S. Wueest et al.   DIABETOLOGIA

Increased Energy Expenditure Contributes More to the Body Weight-Reducing Effect of Rimonabant than Reduced Food Intake in Candy-Fed Wistar Rats

(2008) Andreas W. Herling et al.   ENDOCRINOLOGY

Reversal of visceral adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant

(2008) A W Herling et al.   INTERNATIONAL JOURNAL OF OBESITY

Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats

(2008) I Kunz et al.   INTERNATIONAL JOURNAL OF OBESITY

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

Long-term Effects of Large-volume Liposuction on Metabolic Risk Factors for Coronary Heart Disease

(2008) B. Selma Mohammed et al.   Obesity